112 results
8-K
EX-99.1
w26eya49el3o fp23v
12 Feb 24
Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
4:00pm
8-K
EX-99.1
8yjd5
9 Nov 23
Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate Update
6:44am
424B4
35xlvfw 1zs4s18
2 Oct 23
Prospectus supplement with pricing info
5:05pm
8-K
EX-1.1
itvzyh180
29 Sep 23
Synlogic Announces Pricing of $21.0 Million Underwritten Public Offering
8:53am
8-K
EX-99.1
3wl gczlqhi
10 Aug 23
Synlogic Reports Second Quarter 2023 Financial Results and Provides Business Update
6:35am
8-K
EX-99.1
oa36x bpye
5 Jun 23
Synlogic Announces Initiation of Synpheny-3 Global, Pivotal Phase 3 Study Evaluating SYNB1934 for Treatment of Phenylketonuria
8:32am